Optically Active Vibrational Spectroscopy of α-Aminoisobutyric Acid Foldamers in Organic Solvents and Phospholipid Bilayers by Lizio, Maria Giovanna et al.
                          Lizio, M. G., Andrushchenko, V., Pike, S. J., Peters, A. D., Whitehead, G. F.
S., Vitórica-Yrezábal, I. J., ... Webb, S. J. (2018). Optically Active
Vibrational Spectroscopy of -Aminoisobutyric Acid Foldamers in Organic
Solvents and Phospholipid Bilayers. Chemistry - A European Journal,
24(37), 9399-9408. https://doi.org/10.1002/chem.201801121
Peer reviewed version
Link to published version (if available):
10.1002/chem.201801121
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Wiley-VCH at https://onlinelibrary.wiley.com/doi/abs/10.1002/chem.201801121 . Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms






Optically-Active Vibrational Spectroscopy of α-Aminoisobutyric 
Acid Foldamers in Organic Solvents and Phospholipid Bilayers 
Maria Giovanna Lizio,[a,b] Valery Andrushchenko,[c]* Sarah J. Pike,[a,b,d] Anna D. Peters,[a,b] George F. S. 
Whitehead,[b] Iñigo J. Vitórica-Yrezábal,[b] Shaun T. Mutter,[a] Jonathan Clayden,[e] Petr Bouř,[c] Ewan W. 
Blanch,[f]* and Simon J. Webb[a,b]* 
  
Abstract: Helical α-aminoisobutyric acid (Aib) foldamers show great 
potential as devices for the communication of conformational 
information across phospholipid bilayers, but determining their 
conformation in bilayers remains a challenge. In the present study, 
Raman, Raman optical activity (ROA), infrared (IR) and vibrational 
circular dichroism (VCD) spectroscopies have been used to analyze 
the conformational preferences of Aib foldamers in solution and 
when interacting with bilayers. A 310-helix marker band at 1665-1668 
cm
-1
 in Raman spectra was used to show that net helical content 
increased strongly with oligomer length. ROA and VCD spectra of 
chiral Aib foldamers provided the chiroptical signature for both left- 
and right-handed 310-helices in organic solvents, with VCD 
establishing that foldamer screw-sense was preserved when the 
foldamers became embedded within bilayers. However, the 
population distribution between different secondary structures was 
perturbed by the chiral phospholipid. These studies indicate that 
ROA and VCD spectroscopies are valuable tools for the study of 
biomimetic structures, such as artificial signal transduction 
molecules, in phospholipid bilayers. 
Introduction 
Foldamers are synthetic oligomers that can fold into defined 
conformations, with long foldamers producing large well-defined 
surfaces that can interact with biopolymers or biomolecular 
assemblies.[1] Given these characteristics, there is much interest 
in applying foldamers to biomimetic chemistry and synthetic 
biology, for example to imitate protein–protein interactions,[2] to 
mimic signal transduction,[3,4] to produce DNA complexes for 
gene delivery,[5] to mimic cell-penetrating peptides[6] and to 
provide antimicrobial activity.[7,8,9] Of the different foldamer 
classes, those containing high proportions of α-aminoisobutyric 
acid (Aib) have a number of attractive features for applications 
as devices within membranes. These features include high 
hydrophobicity and an ability to adopt stable 310-helices, a 
conformation that is stabilized by Aib residues[10,11,12] and 
comprises sequences of three or more type III β-turns.[13] Aib 
foldamers in phospholipid bilayers form ion channels in a length 
dependent manner,[14] and show antibiotic activity[15] that may 
originate from their structural similarity to a naturally occurring 
class of antimicrobial peptide, the peptaibols. Peptaibols contain 
large proportions of Aib, which gives them a high propensity to 
fold into 310-helices.
[10,16] Aib foldamers in 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) bilayers[3b,c] can relay 
(photo)chemical information over multi-nanometer distances,[3,4] 
using external stimuli to induce conformational switching 
between helical screw-senses. However, it is not yet established 
that an Aib foldamer maintains the same conformational 
preference in a DOPC bilayer as it does when dissolved in an 
organic solvent, and if 310-helices are still present whether they 
have the same absolute helical screw-sense. 
In general, determining the folded structures of membrane-
embedded oligomers, such as peptides, is a challenge. 
Unpolarized vibrational spectroscopies may provide some 
insight, as they are well-established for the investigation of 
protein and peptide secondary structure in solution, with 
conformational information principally found in the amide I (1620 
cm-1 to 1680 cm-1) and amide III (1200 cm-1 to 1400 cm-1) 
regions.[17] However, these spectroscopies have not been widely 
applied to the study of 310-helical peptides in solution. The amide 
I maximum peak for 310-helix in infrared (IR) spectra is reported 
at 1662-1666 cm-1,[18,19] but this range is close to that for another 
helical secondary structure, α-helix, which is reported at 1650-
1658 cm-1 and gives peaks with a similar spectral 
shape.[18,20,21,22,23] Other secondary structures give peaks in 
regions around 1633/1684 cm-1 (β-sheet), 1672 cm-1 (turns) and 
1654 cm-1 (disordered).[22] Although some α-amino acid based 
polypeptides, such as (Ala)n, can form 310-helices with a right-
handed screw sense (the same sense as natural α-helices), 
these other conformations can compete. It has been reported 
that the length of the peptide, the proportion of Aib residues and 
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the nature of the solvent can influence the equilibrium between 
310-helix and α-helix.
[24,25] For example, the best known peptaibol, 
alamethicin, folds into an α-helix with some 310-helical character 
at the C-terminus in the solid state,[26] a structure that NMR 
studies have shown is largely maintained in bilayers.[27,28,29] 
 
Figure 1. a) Chemical structures of the achiral foldamers 1-6 (N3AibnO
t
Bu, n = 
1, 3 to 7). b) Chiral foldamers (R)-7, (S)-7, (R)-8, (S)-8, and (S)-9. c) 
Equilibrium between left- and right-handed 310-helical conformations for Aib 
foldamers. d) Effect of different N-terminal caps on the distribution between 
left- and right-handed 310-helical conformations (the helical excess, h.e.). Also 
shown is the color coding used in spectra; black lines for L-amino acid caps, 
red lines for D-amino acid caps, full lines for Phe caps; dashed lines for 
αMeVal caps. 
Optically active techniques, such as vibrational circular 
dichroism (VCD) and Raman optical activity (ROA), offer better 
ways to discriminate between α- and 310-helical conformations. 
Indeed, unlike IR, VCD spectroscopy can distinguish between α- 
and 310-helical conformations.
[30,31] Crucially, both VCD and ROA 
should provide information about the absolute helical sense, 
which is especially important for foldamers and peptaibols with 
large proportions of achiral Aib but very few chiral residues. VCD 
studies have been performed on right-handed 310-helical 
peptides (negatively signed bands at ~1680 cm-1 and 1520 cm-1 
and positive at ~1660 cm-1),[31] but only one instance of ROA 
analysis of a 310-helical peptide has been reported: studies in 
water on a polar heptapeptide with a propensity to adopt a right-
handed screw sense suggested a potential marker band for 310-
helix secondary structure at 1668 cm-1 (with positive sign),[32] 
which was corroborated by theoretical modelling.[33] 
To explore how this proposed 310-helix marker band could 
be exploited for the conformational analysis of Aib foldamers in 
different apolar environments (the reported ROA marker band 
was determined in water), we have performed Raman, ROA, IR 
and VCD spectroscopic studies on a series of homologous 
achiral foldamers and chiral derivatives (Figure 1 a,b). These 
studies aimed to show how optically active vibrational 
spectroscopies can determine both the relative proportion and 
chiral sense of 310-helical structure in Aib foldamers, both in 
organic solvents and bilayer membranes. 
Results and Discussion 
In the absence of a chiral group in the foldamer, racemic Aib 
foldamers exist as a mixture comprising equal populations of 
interconverting right-handed (P) and left-handed (M) 310-helices 
(Figure 1 c). Exchange between M- and P-helical conformations 
is fast on the NMR spectroscopy timescale, with a rate constant 
of ca. 1200 s-1 and an activation barrier per residue of 4.6 
kJ.mol-1.[34] Covalently or non-covalently appending a chiral 
group onto the N-terminus can bias the population distribution 
towards one helical conformation over the other; the extent of 
this bias is reflected in the helical excess (h.e.).[35] For example, 
NMR spectroscopy studies in organic solvents have shown that 
chiral quaternary L-amino acids bearing two different 
substituents at the α-carbon, such as L-α-methylvaline, at the N-
terminus favor a right-handed helix.[12] In contrast, the opposite 
screw-sense preference is found for tertiary residues, such as L-
Phe, at the N-terminus (Figure 1 d).[12] However, the use of NMR 
spectroscopy for conformational analysis is complicated by the 
need to make enantiopure 13C labelled probes[36] or the need to 
use solid state NMR spectroscopy to characterize foldamers 
embedded in phospholipid bilayers.[3b] 
Like the naturally occurring peptaibols, foldamers 1 to 9 have 
both N- and C- termini functionalized. These caps can modulate 
the stability of the 310-helix, e.g. a t-Bu ester induces formation 
of a destabilizing Schellman-like motif at the C-terminus of the 
peptides,[37] whilst an N-terminal Cbz (PhCH2OC(O)) adds an 
extra hydrogen bond that can stabilize the 310-helix.
[14b] 
Nonetheless, Aib foldamers with four residues or more form 310-
helical structures even in the presence of destabilizing capping 
groups. Aib dimer 1 (N3Aib2O
tBu) is too short to form a helical 
structure,[37] whereas Aib tetramer 2 (N3Aib4O
tBu) adopts a 310-
helical conformation in the solid state and appears to adopt the 
same conformation in organic solvents.[37] To confirm that the 






longer foldamers 5 and 6 are folded into well-defined 310-
helices,[38] the crystal structures of heptamer 5 (N3Aib7O
tBu) and 
octamer 6 (N3Aib8O
tBu) were determined (see the ESI). These 
structures confirmed that the compounds adopted homologous 
310-helical conformations in the solid state (Figure 2), with both 
310-helix screw-senses equally present in the unit cell. These 
310-helices have four (for 5) or five (for 6) intramolecular 
hydrogen bonds running down the 310-helix axis (Figure 2), 
suggesting that the 310-helical conformation for these 
compounds should be more stable than that of tetramer 2, which 
has a single hydrogen bond to maintain the helix. 
 
Figure 2. X-ray crystal structures of a) heptamer 5 (N3Aib7O
t
Bu) and b) 
octamer 6 (N3Aib8O
t
Bu) showing 310-helical conformations. Intramolecular 
hydrogen bonds are shown in cyan. Methyl and methylene hydrogens 
removed for clarity; grey = C, blue = N, red = O, white = H. 
Raman spectroscopy of achiral Aib foldamers in organic 
solvents 
 
Aib foldamers have a hydrophobic surface, which facilitates 
membrane insertion, so an organic solvent is needed to dissolve 
them. Chloroform, with a low dielectric constant (relative 
permittivity) of 4.81 and a dipole moment of 1.05 D, has often 
been used to mimic the low polarity found at the center of the 
bilayer.[39] However, if sealed cells are either not available or not 
suitable, the high volatility of chloroform may be a drawback for 
performing measurements that may take many hours, such as 
ROA and VCD. In addition, chloroform vibrational bands can 
interfere with those of the peptide. There is also the potential for 
intermolecular aggregation of longer foldamers at high 
concentrations typically required for ROA experiments (> 40 
mg.mL-1). [D6]DMSO (non-deuterated DMSO has bands in the 
amide I region) is a lower volatility, higher polarity (dielectric 
constant 46.7, dipole moment of 3.96 D) alternative solvent that 
is a good hydrogen bond acceptor, weakening intermolecular 
interactions between foldamers.[40] Although this solvent is 
known to destabilize protein secondary structure[41] and has 
been reported to cause switching from 310- to α-helical 
conformations in peptides,[42] NMR spectroscopy studies of the 
octapeptide CbzAib5(L-Leu)Aib2OMe demonstrated that 310-
helical conformations were preferred over α-helical 
conformations in [D6]DMSO.
[43] Therefore, both solvents were 
assessed to find the most versatile solvent for both Raman and 
ROA spectroscopic measurements. Foldamers N3(Aib)nO
tBu 1-6 
were synthesized, the solids dissolved in either CHCl3 or 
[D6]DMSO to give foldamer concentrations of 121 mg.mL
-1, then 
their Raman and ROA spectra recorded. 
In CHCl3, the amide I region for peptides 1 to 6 (Figure 3 a) 
showed that some compounds displayed broad peaks with clear 
asymmetry, suggesting the coexistence of multiple secondary 
structures in solution. The peaks were therefore deconvoluted, 
using resolution-enhancing methods such as second 
derivatives,[22,44] in order to identify and assign the contributing 
bands, which may provide quantitative information about the 
relative contributions of different secondary structures.[45] Band 
deconvolution on the amide I region of foldamers 1 - 6 (Figure 3 
and Table 1) showed that there were two chief contributors in 
this region, at 1661-1668 cm-1 (band 1) and 1679-1692 cm-1 
(band 2). 
 
Table 1. Amide I frequencies (cm
-1
) and relative integral intensities of the 
Raman spectra of N3(Aib)nO
t
Bu foldamers 1 - 6. n/a = not observed. 
Foldamer Amide I, band 1 Amide I, band 2 Solvent 
1 (n = 2) n/a 1681 (100 %) CHCl3 
1 (n = 2) n/a 1674 (91%), 1684 (9%) [D]6DMSO 
2 (n = 4) 1667 (40%) 1688 (60%) CHCl3 
2 (n = 4) 1662 (38%) 1685 (62%) [D]6DMSO 
3 (n = 5) 1666 (27%) 1682 (59%), 1692 (14%) CHCl3 
4 (n = 6) 1661 (27%) 1679 (73%) CHCl3 
4 (n = 6) 1668 (90%) 1688 (10%) [D]6DMSO 
5 (n = 7) 1666 (64%) 1680 (36%) CHCl3 
6 (n = 8) 1688 (100%) n/a CHCl3 
 
The shortest foldamer, Aib dimer 1, is too short to form the type 
III β-turn found in 310-helices and presents a single peak at 1681 
cm-1 (100 %), with a further peak for the ester carbonyl at ca. 
1730 cm-1. However, tetramer 2, which is long enough to form a 
single turn, revealed a shoulder at 1667 cm-1 and a main band at 
1688 cm-1 (Figure 3 a, n = 4, ester peak at ca. 1730 cm-1), with 
an approximate population distribution of 40% and 60%. 
Deconvolution of the amide I band for N3Aib5O
tBu 3 revealed 
three components, at 1666, 1682 and 1692 cm-1, whilst the 
amide I profile for N3Aib6O
tBu 4 is formed by peaks at 1661 and 
1679 cm-1 in a 27% to 73% ratio. N3Aib7O
tBu 5 also presents 
two peaks in the same region (at 1666 cm-1 and 1680 cm-1, in a 
64% to 36% ratio), whereas N3Aib8O
tBu 6 generates only one 
peak in the amide I region, at 1668 cm-1 (100%), even after band 
deconvolution. The Raman spectrum suggests that this peptide 
adopts a single conformation in CHCl3, and comparison of these 






data with the X-ray structure (Figure 2 b) allows us to assign the 
band at 1661-1668 cm-1 to the 310-helical conformation. The 
increase in the proportion of foldamer in a 310-helical 
conformation correlates with an increase in the number of 
intramolecular hydrogen bonds that maintain the helical 
structure. The structure of the conformation that gives the higher 
wavenumber band (band 2) is unclear, although the observation 
that Aib dimer 1 only gives the 1681 cm-1 band suggests that it 
arises from a predominantly unfolded state. 
 
Figure 3. a) Experimental back-scattered Raman spectra for foldamers 1 - 6 
(N3AibnO
t
Bu, n = 2, 4-8) dissolved in CHCl3. The amide I region is shown in 
each case. Peak deconvolutions are shown as gray traces. b,c) Comparison of 
the Raman spectra for foldamers 1, 2 and 4 dissolved in either b) CHCl3 
(green traces) or c) [D6]DMSO (blue traces). The amide I region is shown in 
each case. The vertical dotted line is at 1668 cm
-1
, a wavenumber assigned to 
foldamers in a 310-helical conformation. 
 In [D6]DMSO, the Raman spectra of 1, 2 and 4 generally 
showed small differences (Figure 3 b,c) from those in CHCl3. 
Foldamer 1 in CHCl3 presents one maximum in the amide I 
region at 1681 cm-1, whereas in [D6]DMSO band deconvolution 
reveals the main peak at 1674 cm-1 with a shoulder at 1681 cm-1. 
N3Aib4O
tBu 2 dissolved in [D6]DMSO showed a small shift to 
lower wavenumber in both deconvoluted bands compared to 2 
dissolved in CHCl3 with a negligible change in the population 
distribution (Table 1). The strongest influence from the solvent 
was observed for N3Aib6O
tBu 4. In CHCl3, band deconvolution 
reveals the presence of a shoulder at 1661 cm-1 with a maximum 
peak at 1679 cm-1 (contributions of 27% and 73%, respectively). 
In [D6]DMSO the amide I band is clearly different, with the 
maximum intensity now at 1668 cm-1 and a shoulder at 1688 cm-
1, with band deconvolution showing relative contributions of 90% 
and 10%, respectively. This observation suggests that despite 
the good hydrogen-bond accepting properties of this polar 
solvent, it does not destabilize 310-helical conformations and 
may even increase helical content when a peptide sequence is 
composed mainly of Aib residues; this observation is in 




Raman and ROA spectroscopy of chiral Aib foldamers in 
organic solvents 
 
ROA spectroscopy is a technique that is highly sensitive to 
molecular chirality and structure, and has been used to 
discriminate between conformers of chiral compounds.[46,47,48] 
Although widely applied for the study of α-helical and β-sheet 
structures in proteins, there is only the 2004 report by Toniolo et 
al that describes an ROA spectroscopic investigation of a 310-
helical peptide.[32] In general the most informative part of a 
peptide ROA spectrum is the amide III region,[22,46,49] which has a 
strong contribution from Cα-H deformations. However, this 
contribution is missing for quaternary amino acids, such as Aib, 
so the amide I region becomes a key region of ROA spectra for 
providing information about the secondary structure of peptides 
with high Aib-content or Aib foldamers.[32] 
Aib foldamers 1 to 6 are achiral, so have equal amounts of 
interconverting (P) and (M) 310-helices.
[34] However, adding a 
chiral cap, as in foldamers (R)-7 and (S)-7, biases each 
equilibrium towards one helical screw sense and allows the 
foldamers to be detected using chiroptical spectroscopies. The 
chiral N-terminal phenylalanine “controller” cap in enantiomeric 
foldamers (S)-7 and (R)-7 causes the foldamer body to 
preferably adopt either a left-handed (M) helix (foldamer capped 
with Cbz(L-Phe)) or a right-handed (P) helix (foldamer capped 
with Cbz(D-Phe)) in organic solvents.[12] The extent of this bias is 
determined by the nature of the chiral capping group and can be 
quantified by using NMR spectroscopy to calculate the helical 
excess (h.e.), which for (R)-7 is +40% (e.g. the P:M population 
ratio is 70%:30%).[35] 
A valuable comparison with foldamers (R)-7 and (S)-7 is 
provided by foldamers (R)-8 and (S)-9, which have either one or 
two chiral α-methylvaline (αMeVal) quaternary amino acid 
residues on the N-terminus. Chiral quaternary amino acid 






residues at the N-terminus produce a type III β-turn and induce a 
helical screw sense opposite to tertiary amino acid controllers 
with the same configuration.[12] Therefore capping with D-
αMeVal, as found in (R)-8, gives predominately the left-handed 
310-helix, with an h.e. of −52% (P:M = 24%:76%). Inverting the 
configuration (to L-αMeVal) inverts the h.e. and adding a second 
L-αMeVal, as found in (S)-9, gives better control over the screw-
sense preference, providing an h.e. of +72% (P:M = 
86%:14%).[35] As well as providing a chiral influence, appending 
these residues to the Aib tetramer body can also stabilize the 
helix. The solid state structure of (rac)-8 shows that adding a 
single Cbz-protected residue to the N-terminus of an Aib 
tetramer adds two intramolecular hydrogen bonds, to give three 
hydrogen bonds that stabilize the 310-helix.
[14b] 
 
Figure 4. a) Raman and b) ROA spectra of foldamer (S)-7 (L-Phe cap, left-
handed helix, solid black line) and (R)-7 (D-Phe cap, right-handed helix, solid 
red line). The measurements were carried out at 1.0 W in [D6]DMSO for 48 h 
for each sample. Inset expands the region from 1600 to 1750 cm
-1
. c) ROA 
spectra of foldamer (R)-8 (D-αMeVal cap, left-handed helix, dashed red line) 
and (S)-9 ((L-αMeVal)2 cap, right-handed helix, dashed black line) in CHCl3. 
Inset expands the region from 1600 to 1750 cm
-1
. 
Aib foldamers (R)-7 and (S)-7 were prepared separately by 
chemical synthesis, with the enantiomeric capping residues 
installed in the last synthetic step. The Raman and ROA spectra 
of (R)-7 and (S)-7 were recorded in [D6]DMSO (Figure 4 a,b), 
with the aim of minimizing solvent evaporation and subsequent 
degradation of the samples caused by the strong laser 
irradiation over the 24-48 h course of a typical ROA acquisition. 
Each solution was photobleached in the cell before 
measurement (λ = 532 nm, ca. 2 h, laser power 600 mW at the 
sample) to remove any sample fluorescence. Since Raman 
spectroscopy is not sensitive to chirality, the Raman spectra of 
foldamers (R)-7 and (S)-7 show no significant difference (Figure 
4 a). A strong peak is observed at 1630 cm-1, which arises from 
the aromatic ring of phenylalanine,[50] and the band at 1454 cm-1 
is assigned to an Aib side chain deformation vibration.[51,52] The 
amide I region presents a maximum at ~1680 cm-1 with a 
shoulder at 1664 cm-1; the latter was attributed as a diagnostic 
signature band for 310-helical foldamer. The relatively strong 
intensity of the ~1680 cm-1 band suggests that these short 
foldamers, with only three intramolecular hydrogen bonds, are 
only partially folded into 310-helical structures. 
 The ROA spectra of the two enantiomers present mirror 
image features in the amide I region (Figure 4 b). The ROA 
spectrum of (S)-7 (Cbz(L-Phe)Aib4O
tBu, M helix) shows very 
weak positively signed peaks at 1664 cm-1 and ~1710 cm-1, with 
a stronger negatively signed peak at 1689 cm-1, while foldamer 
(R)-7 (Cbz(D-Phe)Aib4O
tBu, P helix) produces the mirror image 
(very weak negatively signed peaks at 1664 cm-1 and ~1720 cm-
1, with a stronger positively signed peak at 1689 cm-1). The band 
at 1668 cm-1 has been assigned to peptides in a 310-helical 
conformation,[32] whereas the peak at 1689 cm-1 may arise from 
disordered secondary structures.[41] The amide I band for (S)-7 
and (R)-7 appears distinct from an α-helix (right-handed) marker 
band, which is represented by a broad couplet that is negative at 
~1640 cm-1 and positive at ~1665 cm-1.[53,54] The compounds do 
not produce mirror image features in some other regions of the 
spectra, which could be due to differences in foldamer synthesis, 
sample preparation and sample treatment. The appearance of 
the amide I and II regions in the ROA spectra was reproducible, 
with artefacts due to birefringence excluded by repeated 
measurement of freshly prepared samples at different 
concentrations and on different ROA spectrometers (see ESI). 
 To confirm that the amide I signatures observed for (R)-7 
and (S)-7 arose from their secondary structures, foldamers (R)-8 
and (S)-9 were also chemically synthesized and studied. These 
spectra were recorded in CHCl3 as the αMeVal-capped 
foldamers were found to be less susceptible to aggregation than 
(R)-7 and (S)-7. Nonetheless, the high concentrations and the 
long acquisition times required for ROA data collection (between 
24-48 h) caused some visible thermal decomposition of these 
analytes in this solvent; we found no particular advantages using 
CHCl3 over [D6]DMSO. Foldamer (R)-8, which has a D-αMeVal 
cap and should fold into a left-handed helix, showed the inverse 
spectral response to (R)-7, which has a D-Phe cap; the amide I 
region of (R)-8 shows a positive peak at 1660 cm-1 and a 
negative peak at 1680 cm-1 (Figure 4 c). This observation 
suggests that this ROA signature arises from the secondary 
structure adopted by the foldamer rather than the configuration 
of the cap. The longer foldamer (S)-9 (Cbz(L-αMeVal)2Aib4O
tBu), 






with two L-αMeVal residues in the cap, has a conformational 
population that is strongly biased towards right-handed helix. 
Indeed, this foldamer gives many bands of opposite sign to its 
pseudo-enantiomer (R)-8. However, the increase in the length of 
the foldamer, now with four intramolecular hydrogen bonds to 
stabilize the helix, did not strengthen the amide I signature from 
that observed for (R)-8, (R)-7 and (S)-7. 
 The amide I signature for foldamer (R)-7 (Cbz(D-
Phe)Aib4O
tBu, right-handed helix favored) is opposite in sign to 
that reported for a strongly right-handed 310-helical 
heptapeptide,[32] which in H2O shows a small positive signed 
band at ~1668 cm-1. Although (R)-7 favors a right-handed helical 
conformation in solution (P:M ratio of 70:30 in [D4]CH3OH),
[35] 
Raman studies on 1 – 6 revealed that for short foldamers, such 
as 7, 8 and 9, a significant conformational population that is not 
310-helical may be present (up to ca. 75%). Analysis of the ROA 
spectra for these foldamers is therefore complicated by the 
weakness of the bands in the amide I region (perhaps 
exacerbated by oppositely signed contributions from the 
diastereomeric minor M conformer) and the presence of other 
conformations in solution that are not 310-helical but of 
unidentified structure. 
 We note that the ROA spectra of these foldamers will be 
from the ensemble of all of the dynamically interconverting 
conformations adopted in solution. Nonetheless, in the amide I 
region, mirror image ROA bands are reliably observed upon 
inversion of the 310-helical screw sense. 
 
VCD spectroscopy of chiral Aib foldamers in organic 
solvents 
 
VCD spectroscopy is a chiroptical spectroscopic technique that 
is complementary to ROA and has been used to study a number 
of Aib-containing peptides in organic solvents. Much like ROA, 
VCD allows comparison of spectroscopic signatures from α- and 
310-helices. For example, studies of CbzAibn(L-Leu)Aib2OMe (n 
= 0 to 5) in CDCl3 solution carried out by Yasui et al. showed 
that the amide I band for an α-helix (right-handed) is negatively 
biased and intense while the amide I band for a right-handed 
310-helix is only slightly positively biased and weak (negative at 
~1680 cm-1, and positive at ~1660 cm-1).[40] 
In this work, VCD analysis was performed on (R)-7, (S)-7, 
(R)-8 and (S)-8 in [D6]DMSO. The relative intensity and position 
of the amide I and amide II bands in VCD spectra can be used 
to distinguish between -helical and 310-helical secondary 
structures. For -helix, the amide II band is significantly shifted 
from its absorption band and has lower intensity and larger 
bandwidth compared to amide I couplet.[18,55] On the other hand, 
the amide II band for 310-helix is situated much closer to its 
corresponding absorbance peak, is relatively sharp and has 
similar or larger intensity compared to the amide I couplet. 
Inspection of the VCD spectra of (R)-7, (S)-7, (R)-8 and (S)-8 
showed all foldamers had fairly sharp and strong amide II bands, 
which suggests that a significant proportion of these foldamers 
adopts a 310-helical conformation. Multiple measurements on 
fresh solutions of (R)-7 were performed to confirm the 
characteristic features in the spectra (e.g. amide II band shape 
and sign) were reproducible. The αMeVal-capped peptides (S)-8 
and (R)-8 seem to have a higher proportion of 310-helix and/or a 
greater helical excess than the Phe-capped peptides (S)-7 and 
(R)-7, as their amide II VCD signal is slightly more intense than 
their amide I VCD signal and the bands are less shifted from 
their corresponding absorbance bands than in the case of (12-
19 cm-1 vs. 15-22 cm-1 respectively) (Figure 5). 
 
Figure 5. a) VCD spectra of (S)-7 (L-Phe cap, left-handed helix, solid black 
line), (R)-7 (D-Phe cap, right-handed helix, solid red line) in [D6]DMSO; b) 
Corresponding IR spectra of (S)-7 and (R)-7 in [D6]DMSO. c) VCD spectra of 
(R)-8 (D-αMeVal cap, left-handed helix, dashed red line), (S)-8 (L-αMeVal cap, 
right-handed helix, dashed black line) in [D6]DMSO; d) Corresponding IR 
spectra of (R)-8 and (S)-8 in [D6]DMSO. The difference in absorbance 
between enantiomers is ascribed to small variations in sample concentration 
and/or the pathlength of the dismountable VCD cell. 
The VCD spectrum of Cbz(L-Phe)Aib4O
tBu (S)-7 is 
dominated by the negative amide I couplet at 1664(-)/1685(+) 
and the positive amide II band at 1512 cm-1, with corresponding 
absorption bands at 1674 and 1534 cm-1, respectively (Figure 5 
a,b). The VCD spectrum of Cbz(L-Phe)OH indicates that the 
positive VCD signal at 1718 cm-1 and the absorption band at 






1722 cm-1 arise from the chiral Cbz(L-Phe) cap (see the ESI). 
The peptide with the opposite configuration of the cap, Cbz(D-
Phe)Aib4O
tBu (R)-7, shows nearly a mirror image VCD spectrum, 
but differences in sample preparation and treatment may 
produce spectral asymmetry, as well as experimental artefacts 
produced during these challenging measurements. Since the 
VCD spectra of both Cbz(L-Phe)OH and Cbz(D-Phe)OH show 
no bands below 1700 cm-1 (see the ESI), the spectral features 
between 1700 and 1500 cm-1 give information on the secondary 
structure adopted by the Aib oligomers. Bearing in mind that the 
VCD spectral shape is dependent on the relative contributions 
from interconverting diastereomeric conformations (a cap of 
fixed chirality followed by an M or P helical foldamer body), the 
sign of the amide I and II VCD bands is consistent with a 
predominance of left-handed 310-helix for (S)-7 and right-handed 
310-helix for (R)-7, respectively.
[18,55] 
Replacement of the Cbz(L-Phe) cap of (S)-7 with the chiral 
quaternary amino acid Cbz(L-αMeVal) (to give (S)-8) will invert 
the screw sense of the helix, despite the cap having the same 
absolute configuration. Thus, the VCD spectrum of (S)-8 (Cbz(L-
MeVal)Aib4O
tBu) shows a positive amide I couplet at 
1653(+)/1683(-) and negative amide II band at 1520 cm-1, 
possibly arising from the IR bands at 1663 and 1532 cm-1, 
respectively (Figure 5 c,d). Such a VCD pattern corresponds to 
right-handed helix, while the mirror-image VCD of (R)-8 (Cbz(D-
MeVal)Aib4O
tBu) corresponds to left-handed helix;[18,55] both 
observations are in agreement with x-ray crystallography and 
NMR spectroscopy studies.[12] The inverse spectral relationship 
between foldamers capped with Phe and αMeVal of the same 
configuration confirms that VCD bands in the amide I and amide 
II regions are reporting on the conformation of the foldamer 
rather than the chirality of the cap. 
 
VCD spectroscopy of chiral Aib foldamers in phospholipid 
bilayers 
 
The study of Aib foldamer conformation in membranes has 
recently become of keen interest in the area of artificial signal 
transduction,[3,56] with reports that conformational interchange of 
screw-sense in 310-helical Aib foldamers can be used to 
communicate photochemical or chemical signals over multi-
nanometer distances deep into bilayers. These Aib foldamers 
were embedded within vesicles composed of DOPC, which 
gives very fluid bilayers that are commonly used for NMR 
studies of membrane-associated proteins.[57] How the bilayer 
affects Aib foldamer conformation is unclear, although the 
assumption has been made that a 310-helical conformation is still 
formed, with its helical sense the same as in solution.[3c] Indeed, 
solid state NMR spectroscopic analysis of alamethicin in DMPC 
bilayers has shown that this peptaibol largely retains its 
conformation in the bilayer when compared to the x-ray 
crystallographically determined structure.[26,58] 
 It was hoped that VCD analysis would provide some 
insight into the conformations adopted by chiral Aib foldamers 
when they are embedded in DOPC bilayers, although VCD has 
only infrequently been applied to the study of peptides in 
phospholipid bilayers.[59] Several different sizes of DOPC vesicle 
were assessed for their suitability for VCD analysis, including 
giant unilamellar vesicles and large unilamellar vesicles, both of 
which proved to be unsuitable. However, small unilamellar 
vesicles (SUVs) produced through sonication were found to give 
stable suspensions over the lifetimes of the VCD measurements 
without causing too many artefacts in the spectra. The spectrum 
of each foldamer/lipid suspension was measured immediately 
after sample preparation to minimise the effect of changes in 
sample composition over time, for example due to foldamer 
reorganisation in the bilayer, vesicle sedimentation and bilayer 
fusion. For this reason spectral averaging for each sample was 
not carried out, with measurements on fresh samples performed 
instead. 
The VCD and IR spectra of DOPC SUVs without foldamer 
revealed a window from 1700 to 1500 cm-1, which is free of 
strong IR peaks (e.g. lipid C=O stretching at ~1725 cm-1 and 
lipid CH2 bending at ~1460 cm
-1) and VCD bands from the chiral 
glycerol group of DOPC (Figure 6 a,b). DOPC SUVs containing 
foldamers (S)-7 and (R)-7 (lipid:foldamer weight ratio of 4.4:1) 
were prepared in deuterated PBS buffer (PBS salts reconstituted 
in D2O, pD 7.4). 
 The IR spectrum of (S)-7 (Cbz(L-Phe)Aib4O
tBu, M helix) in 
DOPC SUVs showed a complex amide I’ pattern with three 
distinct peaks at 1694, 1671, 1651 cm-1 (Figure 6 d, amide I’ 
denotes an amide I band from peptide in deuterated solvent). 
There is an amide II band at 1520 cm-1, and despite being close 
to a DOPC band, an amide II’ band (for deuterated foldamer) 
that is clearly distinguishable at 1431 cm-1 on the low-
wavenumber shoulder of the lipid CH2 bending mode. A 
combination of amide II and amide II’ bands has been observed 
before for other peptides embedded in lipid bilayers and possibly 
occurs due to incomplete hydrogen-deuterium exchange of the 
amide NH groups.[59d,e] 
 For both foldamers (S)-7 and (R)-7 in bilayers, the intensity 
of the VCD signal was significantly higher (5-10 fold) in the 
bilayer than for the foldamers in [D6]DMSO (see the ESI), which 
could mean that either they become more rigid in the bilayer or 
the helical excess significantly increases (or both of these 
factors). Furthermore, the combined intensity of amide II and 
amide II’ VCD bands is similar to (for (R)-7) or higher than (for 
(S)-7) the amide I’ VCD intensity, while the bands are sharp and 
their position almost coincides with the corresponding IR 
absorption peaks (within a few cm-1). These observations imply 
that foldamer in a bilayer could have a higher 310-helical content 
than when in [D6]DMSO. 
 Foldamer (S)-7 showed a complex amide I’ pattern in the 
VCD spectrum (Figure 6 c), with a positive peak at 1695 and 
negative peaks at 1668 and 1655 cm-1. The complex VCD 
pattern and multiple IR peaks in the amide I’ region seem to 
suggest partitioning of the peptides into a few (two to three) 
conformational subgroups, producing bands that are a 
combination of bands or couplets from all the individual 
subgroups. If we assume that the IR peaks are related to the 
foldamer conformations (and not to foldamer-lipid interactions), 
then we suggest the following assignments: the peaks at 1651-
1652 cm-1 arise from α-helix, bands at 1671-1673 cm-1 
correspond to 310-helix and those at 1694-1696 cm
-1 originate 






from bends and turns.[23,60] The amide II and amide II’ vibrations 
gave rise to positive VCD bands at 1523 and 1432 cm-1, 
respectively. The positive sign of these bands indicates that 
foldamer (S)-7 in the bilayer adopts a left-handed helical 
structure, as found for (S)-7 in organic solvent. 
 
Figure 6. a) VCD spectrum of blank DOPC SUVs in PBS/D2O; 220 mg.mL
-1
; 
50 m path length; BaF2 cell; 29 
°
C (grey trace). b) Corresponding IR spectrum 
of blank DOPC SUVs in PBS/D2O. (c-d) Foldamers (50 mg.mL
-1
) in SUVs (220 
mg.mL
-1
 DOPC). c) VCD spectra of (R)-7 (red line) and (S)-7 (black line) in 
DOPC vesicles. d) Corresponding IR spectra of (R)-7 (red line) and (S)-7 
(black line) in DOPC vesicles. 
 In keeping with the complexity observed for (S)-7, the 
amide I’ VCD spectrum recorded for the enantiomer (R)-7 shows 
several bands with opposite sign (negative peak at 1700 and 
positive at 1668 cm-1). However, the band at 1650 cm-1 
remained negative (Figure 6 c), so the overall amide I’ spectral 
shape does not appear as a mirror image of the corresponding 
region for (S)-7 (1630-1700 cm-1). This could occur due to the 
chiral membrane environment producing different helical 
excesses for these enantiomeric foldamers, resulting in different 
overlap of the individual spectral components. However this 
mixture could only be measured once, so experimental artefacts 
arising from the foldamer-containing vesicles themselves or the 
high sample absorption in this region might also contribute to the 
spectral asymmetry. 
 For (R)-7, the sense of the amide II and amide II’ VCD 
bands at 1527 and 1433 cm-1, respectively, is inverted compared 
to (S)-7. The negative sign of these bands suggests an excess 
of the right-handed helical structure for (R)-7. Therefore, the 
helical screw-sense of both foldamers in the lipid bilayer remains 
the same in DOPC bilayers as in [D6]DMSO solution. Thus, 
analytical studies of Aib foldamer conformation in organic 
solvents can be valuable model systems for studies in bilayers, 
which is a much more challenging environment for quantitative 
analysis. 
Conclusions 
The Raman spectra of Aib foldamers in organic solvents show a 
band at 1661-1668 cm-1 that proportionally increases in intensity 
with increasing foldamer length (dimer to octamer), while a band 
between 1679 and 1688 cm-1 decreases in intensity. For 
example, an Aib dimer that is too short to fold did not show any 
bands at ~1665 cm-1 but an Aib octamer that crystallized as a 
310-helix gave a feature in the ~1665 cm
-1 region almost 
exclusively. We propose that the Raman band at ~1665 cm-1 
results from 310-helical conformations, whereas the Raman band 
at ~1684 cm-1 arises from poorly structured unfolded 
conformations. Although 310-helical content increases strongly 
with the length of Aibn foldamers, to nearly 100% when n = 8, 
Raman spectroscopy can only show the fraction of peptide that 
is in a 310-helical conformation without any information regarding 
the helical sense. Screw-sense inversions (tendril 
perversions)[61] can still occur in the helix between 310-helical 
regions of opposite sense without significantly affecting overall 
310-helix content. 
ROA spectra were obtained for chiral Aib foldamers in 
organic solvents for the first time, identifying an amide I 
signature for partially 310-helical Aib tetramers in organic solvent. 
The ROA spectra of foldamers with different N-terminal chiral 
caps showed the sign of the ROA spectral bands reported on 
foldamer screw-sense rather than the configuration of the N-
terminal controller. These studies suggest ROA could be a 
useful method for investigations of the conformation and stability 
of lipophilic peptaibols in organic solvents, although problems 
with solvent band interference and measurement reproducibility 
remain to be solved. 
VCD spectroscopy of chiral Aib foldamers in [D6]DMSO 
showed that the sign of the VCD bands also reported on the 
foldamer screw-sense rather than on the configuration of the N-
terminal controller. Since it was known that N-terminal L-Phe 
and D-αMeVal both induce a left-handed 310-helical 






conformation,[12] we were able to show that this screw-sense 
resulted in a negative amide I VCD couplet in the 1650-1690 cm-
1 range and a strong sharp positive amide II band at 1520 cm-1 
(with the respective enantiomers showing the converse). These 
findings correlate with earlier VCD studies on right-handed 310-
helical peptides.[31] 
We were also able to obtain IR and VCD spectra of 
tetrameric Aib foldamers capped with either L- or D-Phe in the 
membranes of vesicles at a relatively high loading of 20 wt %. 
The VCD data implies that partitioning into a bilayer increases 
the proportion of foldamer with 310-helical structure, and is also 
consistent with an increase in foldamer rigidity and/or helical 
excess. The sign of a 310-helix marker band at 1520 cm
-1 is the 
same as the sign found in [D6]DMSO, suggesting that the overall 
screw-sense preference of an Aib foldamer in organic solvent is 
retained even after the foldamer partitions into a DOPC lipid 
bilayer. The enantiomers did not give mirror image spectra 
within the 1580-1680 cm-1 window, and a question remains as to 
the cause of these observed differences in the amide I region. 
We suggest either the measurement produced unwanted 
artefacts, most probably due to sample aggregation or 
diminished instrumental sensitivity, or the chiral DOPC lipid 
perturbed the screw-sense equilibrium differently for each 
enantiomeric foldamer. Further investigations are continuing into 
the effect of phospholipid chirality on the conformation of Aib 
foldamers embedded in bilayers. 
Experimental Section 
Peptides 1 to 9 were synthesized according to previously published 
procedures.[14b,37] All samples were re-purified by high-performance liquid 
chromatography (HPLC) on an Agilent (Santa Clara, California, United 
States) 1100 series HPLC equipped with a semi-preparative C-18 
column (Agilent Eclipse XDB-C18, 5 μm, 9.4 mm × 250 mm). 
Single crystals of either N3Aib7O
tBu 5 or N3Aib8O
tBu 6 suitable for X-ray 
diffraction analysis were grown by slow diffusion of diethyl ether into a 
saturated solution of either 5 in chloroform at 23 °C or 6 in chloroform at 
4 °C, respectively. X-ray crystallography details are reported in the 
Supporting Information. Structural data for 5 and 6 have been deposited 
with the Cambridge Crystallographic Data Centre. CCDC 1820749 and 
1820749 contain the supplementary crystallographic data for 5 and 6 
respectively. These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
The vesicle samples for the VCD experiments were obtained by 
combining the appropriate amount of lipid (DOPC) from a stock solution 
(20 mg.mL-1 in chloroform) with the corresponding amount of foldamer 
dissolved in spectroscopic grade chloroform (4 % molar ratio) in a 5 mL 
round-bottomed flask. The chloroform was removed under reduced 
pressure using a rotary evaporator until a thin film was formed on the 
walls of the flask. The film was further dried under high vacuum for at 
least 2 h. Deuterated Dulbecco’s solution was freshly prepared by 
removing the water from commercially available Dulbecco’s solution and 
rehydrated with deuterated water. Drying then resuspension in D2O was 
repeated three times, and the buffer solution was used without further 
treatment. The deuterated Dulbecco’s phosphate buffered saline solution 
(1 mL) was added to the flask and the lipid film was resuspended by 
vortex mixing, then sonicated at room temperature with a sonicator bath; 
samples were freshly prepared before analysis. The final total 
concentration of lipids was around 220 mg.mL-1 in Dulbecco’s solution (1 
mL) and the final foldamer concentration was 50 mg.mL-1. Spectra were 
measured immediately after sample preparation. 
The Raman and ROA spectra of the samples in organic solvents were 
measured at a concentration of 121 mg.mL-1. The samples were 
prepared by dissolving the solid material in [D6]DMSO or CHCl3. The 
samples were transferred into a 200 µL quartz micro-fluorescence cell. 
Each sample was photobleached (532 nm laser for ca. 2 h, laser power 
600 mW at the sample) before measurement to until any fluorescence 
was removed. After complete removal of the fluorescence the Raman 
spectra were acquired.. The experiments were performed using a Chiral 
Raman-2X ROA spectrometer (BioTools, Inc., USA) operated using 
Critical Link (USA) software equipped with a Millennium Pro Nd-VO4 
laser (UK) at 532 nm excitation wavelength, laser power 600 mW at the 
sample, and spectra resolution of 7 cm-1. The spectral acquisition time 
was 42 h. To confirm reproducibility of key spectral features in the amide 
I and II regions, data was collected on samples of (S)-7 and (R)-7 at a 
range of concentrations (53 to 121 mg.mL-1 at 22 °C in temperature-
controlled cells) on two different ROA spectrometers (in Prague and 
Manchester). 
The IR and VCD measurements were performed upon the samples 
extracted from the ROA cell after Raman/ROA experiments. The 
foldamer samples in [D6]DMSO were diluted to 40-50 mg.mL
-1. The 
samples of DOPC and foldamer-DOPC suspensions were prepared in 
D2O-based PBS buffer as described above at concentrations of 220 
mg.mL-1 of DOPC and 50 mg.mL-1 of the peptide to keep the 
lipid:foldamer weight ratio in the final mixture at ca. 4:1. The samples 
were placed in a dismountable BaF2 VCD cell with a pathlength of 50 µm. 
The differences in the pathlength of the dismountable VCD cell, and/or 
small variations in the sample concentration can produce variations in 
sample absorbance. The IR and VCD spectra were acquired with the 
Chiral IR-2X VCD spectrometer (BioTools, Inc., USA) at 8 cm-1 resolution 
for 18 h. To avoid cell and baseline artefacts, solvent spectra were 
measured in the same cell under the same conditions as the samples 
and subtracted from the sample spectra, after which baseline correction 
was performed. Spectra of foldamer solutions were measured once per 
sample, with multiple measurements on (R)-7 performed to confirm that 
characteristic spectral features were reproducible. Spectra of foldamer-
DOPC suspensions were measured once per sample, over several hours 
in 30 minute slots, then averaged to give the final spectrum. 
Raman and ROA spectra were processed using MATLAB 2010 software 
and an in-house toolbox. Conventional Raman spectra were baseline-
corrected according to the method proposed by Eilers et al.[62] The ROA 
spectra were baseline corrected using a 80 point median filter and 
smoothed using a 15 point Savitzky-Golay filter. Spectral deconvolutions 
were carried out in OriginPro 9 using the inbuilt peak fitting and 
deconvolution tool; the area under peaks was measured to obtain 
integral intensities, with second derivatives used to calculate the peak 
centers. The second derivatives were Gaussian peaks iteratively fitted 
until convergence criteria were satisfied. All data were plotted using 
Origin 8.1 Pro software (OriginLab, USA). 
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